Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (CAMP) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study. 1982

M G Trovò, and U Tirelli, and A De Paoli, and G Franchin, and M Roncadin, and M Magri, and E Galligioni, and A Veronesi, and S Tumolo, and A Carbone, and E Grigoletto

Sixty-four consecutive patients with inoperable epidermoid bronchogenic carcinoma (limited disease) were treated with radiotherapy to the primary and nodal areas and combination chemotherapy with cyclophosphamide, adriamycin, methotrexate and procarbazine. The overall response rate (CR + PR) to combined treatment was 62%. The median survival time was 12.7 months. The toxicity was acceptable and no treatment-related death occurred.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011344 Procarbazine An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. Matulane,Natulan,Procarbazine Hydrochloride,Procarbazine Monohydrobromide,Procarbazine Monohydrochloride,Hydrochloride, Procarbazine,Monohydrobromide, Procarbazine,Monohydrochloride, Procarbazine
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D002283 Carcinoma, Bronchogenic Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA. Carcinoma, Bronchial,Bronchial Carcinoma,Bronchial Carcinomas,Bronchogenic Carcinoma,Bronchogenic Carcinomas,Carcinomas, Bronchial,Carcinomas, Bronchogenic
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271

Related Publications

M G Trovò, and U Tirelli, and A De Paoli, and G Franchin, and M Roncadin, and M Magri, and E Galligioni, and A Veronesi, and S Tumolo, and A Carbone, and E Grigoletto
October 1978, Cancer treatment reports,
M G Trovò, and U Tirelli, and A De Paoli, and G Franchin, and M Roncadin, and M Magri, and E Galligioni, and A Veronesi, and S Tumolo, and A Carbone, and E Grigoletto
September 1976, Cancer treatment reports,
M G Trovò, and U Tirelli, and A De Paoli, and G Franchin, and M Roncadin, and M Magri, and E Galligioni, and A Veronesi, and S Tumolo, and A Carbone, and E Grigoletto
December 1978, JAMA,
M G Trovò, and U Tirelli, and A De Paoli, and G Franchin, and M Roncadin, and M Magri, and E Galligioni, and A Veronesi, and S Tumolo, and A Carbone, and E Grigoletto
January 1981, Cancer treatment reports,
M G Trovò, and U Tirelli, and A De Paoli, and G Franchin, and M Roncadin, and M Magri, and E Galligioni, and A Veronesi, and S Tumolo, and A Carbone, and E Grigoletto
December 1976, Cancer,
M G Trovò, and U Tirelli, and A De Paoli, and G Franchin, and M Roncadin, and M Magri, and E Galligioni, and A Veronesi, and S Tumolo, and A Carbone, and E Grigoletto
May 1977, JAMA,
M G Trovò, and U Tirelli, and A De Paoli, and G Franchin, and M Roncadin, and M Magri, and E Galligioni, and A Veronesi, and S Tumolo, and A Carbone, and E Grigoletto
June 1978, European journal of cancer,
M G Trovò, and U Tirelli, and A De Paoli, and G Franchin, and M Roncadin, and M Magri, and E Galligioni, and A Veronesi, and S Tumolo, and A Carbone, and E Grigoletto
August 1972, Cancer,
M G Trovò, and U Tirelli, and A De Paoli, and G Franchin, and M Roncadin, and M Magri, and E Galligioni, and A Veronesi, and S Tumolo, and A Carbone, and E Grigoletto
January 1955, Tip Fakultesi mecmuasi,
M G Trovò, and U Tirelli, and A De Paoli, and G Franchin, and M Roncadin, and M Magri, and E Galligioni, and A Veronesi, and S Tumolo, and A Carbone, and E Grigoletto
July 1956, Minerva medica,
Copied contents to your clipboard!